Shareholder information
Home / Investor relations / Shareholder information
The Board's aim is to strike a balance between the interest of the business, our financial creditors and our shareholders. Dividends will normally be paid twice a year, with a greater proportion paid as a second interm.
Upcoming events
Annual General Meeting and General Meeting information
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Shareholder forms
You can download a selection of our registrar instruction forms here. If you can't find the form you require please go to the Equiniti Shareview website.
Completed forms should be returned to:
Equiniti
Aspect House
Spencer Road
Lancing
West Sussex
BN99 6DA
For more information, shareholder services and changes to personal details, visit the Equiniti website.
Tax information: Alexion
You can download a copy of Form 8937 prepared in relation to the Alexion transaction here. This form will be available on the AstraZeneca website until 31 December 2031.
Investor enquiries
Main Contacts
Andy Barnett
Head of Investor Relations
Isabel Gibson
Oncology
Christer Gruvris
BioPharmaceuticals
(Cardiovascular, Renal and Metabolism),
Finance & Fixed Income
Rachel Korolyshun
Rare Disease,
Environment, Social and Governance
Morgan Sanford
Oncology
Philip Sparks
BioPharmaceuticals
(Respiratory & Immunology, Vaccines & Immune Therapies)
Lauren Swales
Rare Disease,
Environment, Social and Governance